Özkan Alan

494 total citations
50 papers, 238 citations indexed

About

Özkan Alan is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Özkan Alan has authored 50 papers receiving a total of 238 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Oncology, 26 papers in Pulmonary and Respiratory Medicine and 15 papers in Cancer Research. Recurrent topics in Özkan Alan's work include Breast Cancer Treatment Studies (9 papers), Inflammatory Biomarkers in Disease Prognosis (8 papers) and Radiomics and Machine Learning in Medical Imaging (6 papers). Özkan Alan is often cited by papers focused on Breast Cancer Treatment Studies (9 papers), Inflammatory Biomarkers in Disease Prognosis (8 papers) and Radiomics and Machine Learning in Medical Imaging (6 papers). Özkan Alan collaborates with scholars based in Türkiye, Cambodia and Antigua and Barbuda. Özkan Alan's co-authors include Tuğba Akın Telli, Perran Fulden Yumuk, Özlem Erçelep, Faysal Dane, Serap Kaya, Nalan Akgül Babacan, Mehmet Akif Öztürk, Trevor Jones, Erkin Arıbal and Bilge Aktaş and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Scientific Reports.

In The Last Decade

Özkan Alan

42 papers receiving 236 citations

Peers

Özkan Alan
Yuya Nakamura Japan
Madhup Rastogi India
Maryam Kadivar Iran
Eugenie Du United States
Hiroshi Nanjyo Japan
Audrey Rhee United States
Hiroyuki Otsuka Japan
Young Mi Seol South Korea
Pablo Lobos Argentina
Yuya Nakamura Japan
Özkan Alan
Citations per year, relative to Özkan Alan Özkan Alan (= 1×) peers Yuya Nakamura

Countries citing papers authored by Özkan Alan

Since Specialization
Citations

This map shows the geographic impact of Özkan Alan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Özkan Alan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Özkan Alan more than expected).

Fields of papers citing papers by Özkan Alan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Özkan Alan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Özkan Alan. The network helps show where Özkan Alan may publish in the future.

Co-authorship network of co-authors of Özkan Alan

This figure shows the co-authorship network connecting the top 25 collaborators of Özkan Alan. A scholar is included among the top collaborators of Özkan Alan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Özkan Alan. Özkan Alan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Alan, Özkan, et al.. (2025). Neurotoxicity in the Era of Immune Checkpoint Inhibitors: A Case-Based Approach. SHILAP Revista de lepidopterología. 11(1). 50–54.
2.
Alan, Özkan, et al.. (2025). Prognostic Significance of Inflammatory and Nutritional Biomarkers in Patients with Metastatic Gastric Cancer. SHILAP Revista de lepidopterología. 11(1). 14–21. 2 indexed citations
3.
4.
5.
6.
Alan, Özkan, et al.. (2025). Evaluation of Dose Reduction Factors and Impact on Progression-Free Survival in Patients Treated with CDK 4/6 Inhibitors. Journal of Clinical Medicine. 14(4). 1071–1071. 3 indexed citations
7.
Alan, Özkan, et al.. (2024). Prognostic Impact and Clinical Features of Spread through Air Spaces in Operated Lung Cancer: Real-World Analysis. Medicina. 60(8). 1374–1374. 4 indexed citations
8.
Uğurlu, Mustafa Ümit, et al.. (2024). Neoadjuvant Chemotherapy Shortens the cfDNA Telomere Length in Breast Cancer Patients. International Journal of Breast Cancer. 2024(1). 6117394–6117394. 1 indexed citations
9.
Alan, Özkan, et al.. (2024). Evaluating the Effectiveness of Nivolumab in Metastatic Lung Cancer Among Patients Aged 65 and Older. Journal of Clinical Medicine. 13(20). 6263–6263. 1 indexed citations
10.
Alan, Özkan, et al.. (2023). Outcomes of surveillance versus adjuvant treatment for patients with stage-I seminoma: a single-center experience. World Journal of Urology. 41(8). 2201–2207. 1 indexed citations
11.
Pilancı, Kezban Nur, et al.. (2023). Clinical and inflammation marker features of cancer patients with COVID-19: data of Istanbul, Turkey multicenter cancer patients (2020–2022). Current Medical Research and Opinion. 39(7). 987–996. 5 indexed citations
12.
Telli, Tuğba Akın, Özkan Alan, Bülent Erol, et al.. (2022). Impact of Skeletal Muscle Measurements by Chest Computed Tomography on Survival and Postoperative Complications in Patients with Soft Tissue Sarcoma. Nutrition and Cancer. 74(7). 2499–2507. 1 indexed citations
13.
Telli, Tuğba Akın, Mehmet Akif Öztürk, Özkan Alan, et al.. (2022). Real-world assessment of quality-of-life in patients with breast cancer treated with adjuvant endocrine therapy. Future Oncology. 18(22). 2425–2439.
14.
Telli, Tuğba Akın, İlker Ökten, Özkan Alan, et al.. (2020). VEGF-VEGFR pathway seems to be the best target in hepatic epithelioid hemangioendothelioma: A case series with review of the literature. Current Problems in Cancer. 44(5). 100568–100568. 11 indexed citations
15.
Alan, Özkan, Tuğba Akın Telli, Özlem Erçelep, et al.. (2020). Prognostic value of modified Glasgow prognostic score in recurrent high-grade glial tumors treated with systemic treatment. Clinical Neurology and Neurosurgery. 196. 105976–105976. 4 indexed citations
16.
Erçelep, Özlem, Özkan Alan, Tuğba Akın Telli, et al.. (2020). Differences in PET/CT standardized uptake values involvement and survival compared to histologic subtypes of lung adenocarcinoma. Tumori Journal. 107(3). 231–237. 5 indexed citations
17.
Alan, Özkan, Tuğba Akın Telli, Özlem Erçelep, et al.. (2020). Prognostic factors in progressive high-grade glial tumors treated with systemic approach: A single center experience. Journal of Oncology Pharmacy Practice. 27(2). 329–339. 2 indexed citations
18.
Akkіprіk, Mustafa, Mustafa Ümit Uğurlu, Özkan Alan, et al.. (2020). Response Assessment With Molecular Characterization of Circulating Tumor Cells and Plasma MicroRNA Profiling in Patients With Locally Advanced Breast Cancer During Neoadjuvant Chemotherapy. Clinical Breast Cancer. 20(4). 332–343.e3. 7 indexed citations
19.
Alan, Özkan, et al.. (2019). MEAN PLATELET VOLUME (MPV) FOR PREDICTING PROGNOSIS OF RECTUM CANCER AFTER NEOADJUVANT TREATMENT. SHILAP Revista de lepidopterología. 7(3). 279–286. 2 indexed citations
20.
Canbakan, Billur, Özkan Alan, İbrahim Hatemı, et al.. (2017). Evaluation of non-invasive diagnostic methods as indicators of fibrosis in patients with nonalcoholic fatty liver disease. Biomedical Research-tokyo. 28(2). 565–570. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yuya Nakamura Breakdown of academic impact, for papers by Madhup Rastogi Breakdown of academic impact, for papers by Maryam Kadivar Breakdown of academic impact, for papers by Eugenie Du Breakdown of academic impact, for papers by Hiroshi Nanjyo Breakdown of academic impact, for papers by Audrey Rhee Breakdown of academic impact, for papers by Hiroyuki Otsuka Breakdown of academic impact, for papers by Young Mi Seol Breakdown of academic impact, for papers by Pablo Lobos
Rankless by CCL
2026